According to Day One Biopharmaceuticals's latest financial reports the company has a price-to-book ratio of 4.44455.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2025-12-31 | N/A | -100% |
2024-12-31 | 2.58 | -29.6% |
2023-12-31 | 3.67 | -23.07% |
2022-12-31 | 4.77 | 28.43% |
2021-12-31 | 3.71 | |
2020-12-31 | N/A |